<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Halozyme Therapeutics, Inc.

    Halozyme Therapeutics, Inc.

    Halozyme is a clinical-stage biotechnology company focused on developing and comme...

    Halozyme is a clinical-stage biotechnology comp...

    Filing Type:    PU
    SIGA Technologies Inc.

    SIGA Technologies Inc.

    SIGA Technologies, Inc. is a public, commercial-stage pharmaceutical company focus...

    SIGA Technologies, Inc. is a public, commercial...

    Filing Type:    PU
    Ligand Pharmaceuticals Incorporated

    Ligand Pharmaceuticals Incorporated

    Ligand is a biopharmaceutical company focused on developing or acquiring technolog...

    Ligand is a biopharmaceutical company focused o...

    Filing Type:    PU
    Oxford Immunotec Global PLC

    Oxford Immunotec Global PLC

    We are a global, high-growth diagnostics company committed to improving patient ca...

    We are a global, high-growth diagnostics compan...

    Filing Type:    PU
    Intrexon Corporation

    Intrexon Corporation

    Intrexon Corporation (NASDAQ: XON) is Powering the Bioindustrial Revolution with B...

    Intrexon Corporation (NASDAQ: XON) is Powering ...

    Filing Type:    PU
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapie...

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)...

    Filing Type:    PU
    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the ...

    Salarius Pharmaceuticals, Inc. is a clinical-st...

    Filing Type:    PU
    FibroGen, Inc

    FibroGen, Inc

    FibroGen, Inc. is a leading science-based biopharmaceutical company discovering an...

    FibroGen, Inc. is a leading science-based bioph...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.